Meeting
2022 ASCO Annual Meeting
Multi-omic and spatial dissection of immunotherapy response groups in non–small cell lung cancer (NSCLC).
Authors
Kenneth John O'Byrne
Princess Alexandra Hospital Brisbane, Queensland, Australia
Kenneth John O'Byrne , James Monkman , Honesty Kim , Marie Cumberbatch , Milan Bhagat , Rahul Ladwa , Mark N Adams , Arutha Kulasinghe
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Local-Regional/Small Cell/Other Thoracic Cancers
Track
Lung Cancer
Sub Track
Local-Regional Non–Small Cell Lung Cancer
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 8544)
DOI
10.1200/JCO.2022.40.16_suppl.8544
Abstract #
8544
Poster Bd #
171
Abstract Disclosures
Similar Posters
Poster
2020 ASCO-SITC Clinical Immuno-Oncology Symposium
Association of immune microenvironment to response in treatment-naïve non-small cell lung cancer (NSCLC) samples with follow-up second-line immunotherapy data.
First Author: Marie Cumberbatch
Poster
2017 ASCO Annual Meeting
Gene expression analysis of tumor biopsies from a trial of durvalumab to identify subsets of NSCLC with shared immune pathways.
First Author: Katie Streicher
Poster
2023 ASCO Gastrointestinal Cancers Symposium
Beyond CPS for PD-L1 scoring: Genetic alterations that impact efficacy of immunotherapy in hepatocellular carcinoma (HCC).
First Author: Emil Lou
Poster
2019 ASCO Annual Meeting
Feasibility study of microbial ecosystem therapeutics (MET-4) to evaluate effects of fecal microbiome in patients on immunotherapy (MET4-IO).
First Author: Tira Jing Ying Tan